These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2138704)

  • 1. [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease].
    Unterberg C; Buchwald A; Vogt A; Wiegand V
    Med Klin (Munich); 1990 Feb; 85(2):78-81. PubMed ID: 2138704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
    Bauer B; Lorenz H; Zahlten R
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
    de Graeff PA; Kingma JH; Dunselman PH; Wesseling H; Lie KI
    Am J Cardiol; 1987 Apr; 59(10):164D-170D. PubMed ID: 3034026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study].
    Odenthal HJ; Thürmann P; Wiechmann HW; Josephs W; Lenga P
    Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in cough reflex after treatment with enalapril and ramipril.
    McEwan JR; Choudry N; Street R; Fuller RW
    BMJ; 1989 Jul; 299(6690):13-6. PubMed ID: 2547470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
    Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
    Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.
    Heber ME; Brigden GS; Caruana MP; Lahiri A; Raftery EB
    Am J Cardiol; 1988 Aug; 62(4):239-45. PubMed ID: 2969671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease.
    Thürmann P; Rietbrock N
    Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.
    Kindler J; Schunkert H; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Ritz E; Sieberth HG
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S55-8. PubMed ID: 2474105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo.
    Villamil AS; Cairns V; Witte PU; Bertolasi CA
    Am J Cardiol; 1987 Apr; 59(10):110D-114D. PubMed ID: 3034017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on autonomic function of a new angiotensin converting enzyme inhibitor, ramipril.
    Sugimoto K; Kumagai Y; Tateishi T; Seguchi H; Ebihara A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S40-4. PubMed ID: 2474100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    Am J Cardiol; 1987 Apr; 59(10):155D-163D. PubMed ID: 3034025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus.
    Janka HU; Nuber A; Mehnert H
    Arzneimittelforschung; 1990 Apr; 40(4):432-5. PubMed ID: 2141472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO; van Baak MA; Rahn KH
    Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitors after myocardial infarction.
    Hall AS; Ball SG
    Lancet; 1989 Dec 23-30; 2(8678-8679):1527. PubMed ID: 2574802
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of ramipril.
    Ball SG; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.